form8-k.htm
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):  May 24, 2013

MYLAN INC.
(Exact Name of Registrant as Specified in Charter)

 
Pennsylvania
 
1-9114
 
25-1211621
(State or Other Jurisdiction of Incorporation)
 
(Commission File Number)
 
(I.R.S. Employer Identification No.)
         

1500 Corporate Drive, Canonsburg, PA
 
 
15317
(Address of Principal Executive Offices)
 
(Zip Code)

Registrant’s telephone number, including area code: (724) 514-1800

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 
£
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
£
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
£
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2 (b))
 
£
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4 (c))

 
 

 

Item 5.07.             Submission of Matters to a Vote of Security Holders.
 
The 2013 Annual Meeting of Shareholders of Mylan Inc. (the “Company”) was held on May 24, 2013 to (i) elect thirteen members of the Board of Directors for one year terms; (ii) ratify the appointment of Deloitte & Touche LLP as its independent registered public accounting firm; (iii) approve, on an advisory basis, the compensation of the Named Executive Officers of the Company, as disclosed in the Proxy Statement; and (iv) consider a shareholder proposal requesting the adoption of a mandatory policy requiring that the Chairman of the Board of Directors be an independent Director.
 
As of March 22, 2013, the record date for the Annual Meeting, there were 382,710,089 shares of common stock outstanding and entitled to vote. At the Annual Meeting, approximately 303,517,781 shares of common stock were represented in person or by proxy, constituting a quorum. The certified results of the matters voted on at the Annual Meeting are set forth below.
 
Proposal No. 1 – Elect the following thirteen directors, each for a term of one year:
 
 
For
 
Against
 
Abstain
 
Broker Non-Votes
Heather Bresch
260,211,010
 
3,970,967
 
6,953,513
 
32,382,291
Wendy Cameron
244,270,900
 
17,142,083
 
9,722,504
 
32,382,293
Robert J. Cindrich
259,641,969
 
1,760,491
 
9,733,030
 
32,382,290
Robert J. Coury
258,778,975
 
5,309,787
 
7,046,726
 
32,382,292
Neil Dimick, C.P.A.
229,609,477
 
31,844,796
 
9,681,217
 
32,382,290
Melina Higgins
261,430,378
 
2,599,221
 
7,105,892
 
32,382,289
Douglas J. Leech, C.P.A.
258,133,428
 
3,318,807
 
9,683,253
 
32,382,291
Rajiv Malik
260,368,054
 
3,787,198
 
6,980,239
 
32,382,289
Joseph C. Maroon, M.D.
245,005,887
 
15,742,485
 
10,430,548
 
32,338,861
Mark W. Parrish
259,882,269
 
1,559,479
 
9,698,744
 
32,382,288
Rodney L. Piatt, C.P.A.
246,068,258
 
15,400,800
 
9,665,833
 
32,382,289
C.B. Todd
257,365,913
 
3,929,609
 
9,839,967
 
32,382,291
Randall L. (Pete) Vanderveen, Ph.D., R.Ph., C.P.A
258,320,492
 
3,225,371
 
9,589,626
 
32,382,290

 
Proposal No. 2 – Ratify the selection of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2013:
 
For
 
Against
 
Abstain
 
Broker Non-Votes
291,898,777
 
4,268,282
 
7,307,291
 
43,429

 
Proposal No. 3 – Approve, on an advisory basis, the compensation of the Named Executive Officers of the Company, as disclosed in the Proxy Statement:
 
For
 
Against
 
Abstain
 
Broker Non-Votes
185,440,201
 
80,499,909
 
5,195,372
 
32,382,297

 
Proposal No. 4 – Consider a shareholder proposal requesting the adoption of a mandatory policy requiring that the Chairman of the Board of Directors be an independent Director:
 
For
 
Against
 
Abstain
 
Broker Non-Votes
111,935,681
 
157,406,691
 
1,793,109
 
32,382,299
 
 
 

 
 
SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 

 
MYLAN INC.
Date: May 24, 2013
By:  
/s/ John D. Sheehan
   
John D. Sheehan
   
Executive Vice President and Chief Financial Officer